课题基金 / 基金详情

Can genetic polymorphisms explain the cardiovascular risk of nonsteroidal anti-inflammatory drugs?

Can genetic polymorphisms explain the cardiovascular risk of nonsteroidal anti-inflammatory drugs?
基因多态性可以解释非甾体抗炎药的心血管风险吗？
批准号：
183805
负责人：
Brophy James M
金额：
$7.29万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2008
资助国家：
加拿大
项目状态：
已结题
起止时间：
2008-10-01 至 2009-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=183805&lang=en
关键词：
Cardiovascular Safety Gene*Drug Interaction Genetic Polymorphisms Genome Wide Association Studies Nsaids Pharmacogenomics

项目摘要

项目成果

Brophy James M的其他基金

相关文献

中文摘要
翻译
抗炎药（NSAID）被广泛用于发热，疼痛和炎症。NSAIDs是当今最常见的处方药，具有显著的健康益处。然而，最近的研究引起了关注和争议
英文摘要
Anti-inflammatory drugs (NSAIDs) are widely used for fever, pain and inflammation. NSAIDs are the most common class of drug prescribed today and are associated with significant health benefits. However, recent studies have raised concerns and controversy
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Evaluating the Trajectory of Aortic Stenosis (AS) in Quebec patients - Diagnosis, Treatments, and Outcomes
Ticagrelor compared to clopidogrel in acute coronary syndromes - the TC4 comparative effectiveness study
Comparative effectiveness research for the drug treatment of atrial fibrillation.